Morphine Sulfate 00409-2022-01
- Manufacturer
- Hospira, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- April 21, 2025
- Listing Expires
- December 31, 2027
- Application
- NDA202515
Active Ingredients
| Ingredient | Strength |
|---|---|
| Morphine Sulfate | 50 mg/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Selected Package
00409-2022-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (0409-2022-01) / 50 mL in 1 VIAL, SINGLE-DOSE